Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
InheRET empowering individuals to accurately identify their risk for hereditary conditions.
QT Imaging is a scanning center that provides breast imaging by tomographic transmission ultrasound for patients.
TransCode Therapeutics is an RNA oncology company that develops and commercializes drugs for the treatment of metastatic cancer.
MALCOVA is a medical device startup delivering novel hardware and AI-based software solutions to resolve needs in the radiology market.
Georgia Cancer Center provides industry-leading cancer research and care that benefits patients locally and globally.
Isabl develops cancer diagnostic tests based on whole genome and RNA sequencing data.
Sinopia Biosciences enables data-driven drug discovery by means of multi-omics data, machine learning, network analyses, and disease models.
Ramona develops high-throughput microscopy tools to unlock previously impossible experiments within the modern biology lab.
GigaMune is a biotech firm focused on engineered TCR-Treg cell therapies for autoimmune diseases, including Type 1 Diabetes.
Navega Therapeutics is a preclinical stage company developing epigenetic gene therapies for neurological and ophthalmic diseases.
Resolute is advancing a first-in-class platform of cytotoxics and radiotherapeutics for aggressive and hard to treat solid tumors.
Linnaeus Therapeutics is a development stage biotech company that develops and commercializes drugs for cancer.
mPath Health is a cloud-based automation software platform that helps to improve preventive care.
Symple Surgical is a medical device company focusing on developing novel therapeutic technologies through controlled microwave ablation.
OnLume provides intuitive and ergonomic solutions for the integration of precise fluorescence image-guided surgery.
Pioneering in-human click chemistry against cancer
Veana Therapeutics is a Biotechnology Company based in Oregon.
ZetaGen Therapeutics commercializes a small molecule-based osteoinductive platform.
Tiga TX develops an IgA therapeutic monoclonal antibody platform for the treatment of solid tumors.
Trethera is a biotechnology company that discovers and develops small molecules that control DNA replication and integrity.
Vivere develops targeted cancer therapies that activate the immune system to detect and destroy tumors using engineered bio-platforms.
Paramita Therapeutics is a biotech company that focuses on developing new cancer and infectious disease therapeutics.
We help healthcare and life sciences organizations to accelerate evidence-based decisions using real-world data, AI, and outcomes research.
We are exosomes! We can extract any species of pure, viable, in-tact exosome from any biofluid source into pure solution.
National Cancer Institute has invested in 99 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Cancer Institute's top investment sectors include Health Care, Biotechnology, Therapeutics, Medical, Medical Device. The firm invests across 28 different industry categories.
Among tracked funding rounds, Tiga TX received $35.5M in a Grant round. National Cancer Institute's total known invested capital is $319.4M.
National Cancer Institute's average investment size is $3.9M across its portfolio of 99 companies.
Recent National Cancer Institute portfolio additions include InheRET, QT Imaging, Transcode Therapeutics, MALCOVA, Georgia Cancer Center. These companies were founded in 2020 or later.